0001123292-17-001446.txt : 20170928 0001123292-17-001446.hdr.sgml : 20170928 20170928171443 ACCESSION NUMBER: 0001123292-17-001446 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170719 FILED AS OF DATE: 20170928 DATE AS OF CHANGE: 20170928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danilkovitch Alla CENTRAL INDEX KEY: 0001636236 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32966 FILM NUMBER: 171108313 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE STREET 2: OSIRIS THERAPEUTICS, INC. CITY: COLUMBIA STATE: MD ZIP: 21046 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001360886 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 710881115 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 443-545-1819 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-07-19 0001360886 OSIRIS THERAPEUTICS, INC. OSIR 0001636236 Danilkovitch Alla 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 0 1 0 0 Chief Scientific Officer Incentive Stock Option (right to buy) 6.80 2017-07-19 4 A 0 34534 6.80 A 2018-07-19 2027-07-19 Common Stock 34534 125534 D Non-qualified Stock Option (right to buy) 6.80 2017-07-19 4 A 0 15466 6.80 A 2018-07-19 2027-07-19 Common Stock 15466 139000 D 25% of the shares underlying this option shall vest on each of July 19, 2018, July 19, 2019, July 19, 2020 and July 19, 2021, subject to Reporting Person's continued service through the applicable vesting date. /s/ Alla Danilkovitch 2017-09-28